Dennis H. Giesing
2022
In 2022, Dennis H. Giesing earned a total compensation of $715.6K as Chief Development Officer at Immunome, a 80% decrease compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $115,500 |
| Option Awards | $108,930 |
| Salary | $385,000 |
| Other | $6,193 |
| Total | $715,623 |
Giesing received $385K in salary, accounting for 54% of the total pay in 2022.
Giesing also received $100K in bonus, $115.5K in non-equity incentive plan, $108.9K in option awards and $6.2K in other compensation.
Rankings
In 2022, Dennis H. Giesing's compensation ranked 3,728th out of 5,760 executives tracked by ExecPay. In other words, Giesing earned more than 35.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,728 out of 5,760 | 35th |
Division Manufacturing | 2,109 out of 3,136 | 33rd |
Major group Chemicals And Allied Products | 1,018 out of 1,422 | 28th |
Industry group Drugs | 954 out of 1,323 | 28th |
Industry Pharmaceutical Preparations | 697 out of 969 | 28th |
Source: SEC filing on April 20, 2023.
Giesing's colleagues
We found two more compensation records of executives who worked with Dennis H. Giesing at Immunome in 2022.